These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 2326839

  • 1. Elevated plasma homocyst(e)ine concentration as a possible independent risk factor for stroke.
    Coull BM, Malinow MR, Beamer N, Sexton G, Nordt F, de Garmo P.
    Stroke; 1990 Apr; 21(4):572-6. PubMed ID: 2326839
    [Abstract] [Full Text] [Related]

  • 2. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease.
    Taylor LM, DeFrang RD, Harris EJ, Porter JM.
    J Vasc Surg; 1991 Jan; 13(1):128-36. PubMed ID: 1987384
    [Abstract] [Full Text] [Related]

  • 3. A prospective study of plasma homocyst(e)ine and risk of ischemic stroke.
    Verhoef P, Hennekens CH, Malinow MR, Kok FJ, Willett WC, Stampfer MJ.
    Stroke; 1994 Oct; 25(10):1924-30. PubMed ID: 8091435
    [Abstract] [Full Text] [Related]

  • 4. 677C to T mutation in the 5,10-methylenetetrahydrofolate reductase (MTHFR) gene and plasma homocyst(e)ine levels in patients with TIA or minor stroke.
    Lalouschek W, Aull S, Korninger L, Mannhalter C, Pabinger-Fasching I, Schmid RW, Schnider P, Zeiler K.
    J Neurol Sci; 1998 Mar 05; 155(2):156-62. PubMed ID: 9562260
    [Abstract] [Full Text] [Related]

  • 5. Relation of plasma homocyst(e)ine to cerebral infarction and cerebral atherosclerosis.
    Yoo JH, Chung CS, Kang SS.
    Stroke; 1998 Dec 05; 29(12):2478-83. PubMed ID: 9836754
    [Abstract] [Full Text] [Related]

  • 6. Hyperhomocyst(e)inemia and the prevalence of atherosclerotic vascular disease in patients with end-stage renal disease.
    Manns BJ, Burgess ED, Hyndman ME, Parsons HG, Schaefer JP, Scott-Douglas NW.
    Am J Kidney Dis; 1999 Oct 05; 34(4):669-77. PubMed ID: 10516348
    [Abstract] [Full Text] [Related]

  • 7. Oxidative stress in the context of acute cerebrovascular stroke.
    El Kossi MM, Zakhary MM.
    Stroke; 2000 Aug 05; 31(8):1889-92. PubMed ID: 10926952
    [Abstract] [Full Text] [Related]

  • 8. Hyperhomocyst(e)inemia, anti-estrogen antibodies and other risk factors for thrombosis in women on oral contraceptives.
    Beaumont V, Malinow MR, Sexton G, Wilson D, Lemort N, Upson B, Beaumont JL.
    Atherosclerosis; 1992 Jun 05; 94(2-3):147-52. PubMed ID: 1632868
    [Abstract] [Full Text] [Related]

  • 9. [Homocysteine, endothelial dysfunction and cardiovascular risk: pathomechanisms and therapeutic options].
    Sydow K, Böger RH.
    Z Kardiol; 2001 Jan 05; 90(1):1-11. PubMed ID: 11220081
    [Abstract] [Full Text] [Related]

  • 10. Hyperhomocyst(e)inemia and risk of ischemic stroke among young Asian adults.
    Tan NC, Venketasubramanian N, Saw SM, Tjia HT.
    Stroke; 2002 Aug 05; 33(8):1956-62. PubMed ID: 12154245
    [Abstract] [Full Text] [Related]

  • 11. Hyperhomocyst(e)inemia in renal transplant recipients with and without cyclosporine.
    Ducloux D, Fournier V, Rebibou JM, Bresson-Vautrin C, Gibey R, Chalopin JM.
    Clin Nephrol; 1998 Apr 05; 49(4):232-5. PubMed ID: 9582553
    [Abstract] [Full Text] [Related]

  • 12. Association between high homocyst(e)ine and ischemic stroke due to large- and small-artery disease but not other etiologic subtypes of ischemic stroke.
    Eikelboom JW, Hankey GJ, Anand SS, Lofthouse E, Staples N, Baker RI.
    Stroke; 2000 May 05; 31(5):1069-75. PubMed ID: 10797167
    [Abstract] [Full Text] [Related]

  • 13. Elevated levels of plasma homocyst(e)ine and asymmetric dimethylarginine in elderly patients with stroke.
    Yoo JH, Lee SC.
    Atherosclerosis; 2001 Oct 05; 158(2):425-30. PubMed ID: 11583722
    [Abstract] [Full Text] [Related]

  • 14. Homocysteine metabolism and risk of myocardial infarction: relation with vitamins B6, B12, and folate.
    Verhoef P, Stampfer MJ, Buring JE, Gaziano JM, Allen RH, Stabler SP, Reynolds RD, Kok FJ, Hennekens CH, Willett WC.
    Am J Epidemiol; 1996 May 01; 143(9):845-59. PubMed ID: 8610698
    [Abstract] [Full Text] [Related]

  • 15. Patients with atherosclerotic vascular disease: how low should plasma homocyst(e)ine levels go?
    Spence JD.
    Am J Cardiovasc Drugs; 2001 May 01; 1(2):85-9. PubMed ID: 14728038
    [Abstract] [Full Text] [Related]

  • 16. Homocyst(e)ine and atherosclerosis in patients on chronic hemodialysis.
    Lee YK, Kwon YJ, Yoon JW, Oh KS, Cha DR, Cho WY, Huh K, Pyo HJ, Kim HK.
    J Korean Med Sci; 1999 Apr 01; 14(2):193-8. PubMed ID: 10331567
    [Abstract] [Full Text] [Related]

  • 17. Protein-bound homocyst(e)ine. A possible risk factor for coronary artery disease.
    Kang SS, Wong PW, Cook HY, Norusis M, Messer JV.
    J Clin Invest; 1986 May 01; 77(5):1482-6. PubMed ID: 3700650
    [Abstract] [Full Text] [Related]

  • 18. Plasma homocyst(e)ine: a risk factor for arterial occlusive diseases.
    Malinow MR.
    J Nutr; 1996 Apr 01; 126(4 Suppl):1238S-43S. PubMed ID: 8642463
    [Abstract] [Full Text] [Related]

  • 19. Hyperhomocyst(e)inemia is a risk factor of secondary vascular events in stroke patients.
    Del Ser T, Barba R, Herranz AS, Seijas V, López-Manglano C, Domingo J, Pondal M.
    Cerebrovasc Dis; 2001 Aug 01; 12(2):91-8. PubMed ID: 11490102
    [Abstract] [Full Text] [Related]

  • 20. Hyperhomocyst(e)inemia and endothelial dysfunction in IDDM.
    Hofmann MA, Kohl B, Zumbach MS, Borcea V, Bierhaus A, Henkels M, Amiral J, Schmidt AM, Fiehn W, Ziegler R, Wahl P, Nawroth PP.
    Diabetes Care; 1998 May 01; 21(5):841-8. PubMed ID: 9589252
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.